Search Results

0 results for ''Motley Rice''

You can use to get even better search results
April 04, 2022 | Law.com

West Virginia Bench Trial Opens Over the Opioid Crisis

Three drug companies that won a California bench verdict last year in one of the first opioid trials in the nation went to trial on Monday against West Virginia.
4 minute read
April 04, 2022 | The Legal Intelligencer

Morgan Lewis Lawyer Defends Drugmaker as New Trial Over Opioid Crisis Begins

Three drug companies that won a California bench verdict last year in one of the first opioid trials in the nation went to trial on Monday against West Virginia.
4 minute read
March 22, 2022 | Connecticut Law Tribune

In Elite Company: Announcing 2022's Connecticut Legal Awards Honorees

More than 80 awards featuring 45-plus firms and organizations will be honored in this year's program in May at the Aqua Turf Club.
4 minute read
March 21, 2022 | Law.com

Teva Settles Rhode Island's Opioid Case, Avoiding Trial

Attorney General Peter Neronha announced on Monday that Rhode Island had settled opioid claims against Teva and Allergan for a total value of about $107 million.
4 minute read
March 16, 2022 | Law.com

Associate Laterals Are Slowing: The Morning Minute

The news and analysis you need to start your day.
5 minute read
March 15, 2022 | Law.com

Motley Rice, Morgan Lewis Square Off Again as Opioid Jury Trial Opens in Rhode Island

A jury trial over the opioid crisis begins in Rhode Island this week with Morgan, Lewis & Bockius against Motley Rice, two law firms that previously faced off in California.
3 minute read
March 15, 2022 | Daily Report Online

Georgia Will Help Decide Who Gets the $2.3B in Legal Fees in the Global Opioid Deal

The fees and costs outlined in the $26 billion opioid deal with Johnson & Johnson's Janssen Pharmaceuticals and three distributors are a mix of common benefit fees, contingency fees and payments to the states for outside counsel. One law professor said, "it's not like the lawyers are going to be impoverished."
9 minute read
March 11, 2022 | New York Law Journal

2nd Circuit Upholds Dismissal of Securities Suit Targeting Bristol-Myers Squibb Over Failed Trial

The panel upheld a lower court's dismissal of a proposed securities class action, which claimed that Bristol-Myers Squibb made material misstatements or omissions around a clinical trial to determine the drug's efficacy for treating certain kinds of lung cancers.
3 minute read
March 11, 2022 | Law.com

Who Gets the $2.3 Billion in Legal Fees in the Global Opioid Deal?

The fees and costs outlined in the $26 billion opioid deal with Johnson & Johnson's Janssen Pharmaceuticals and three distributors are a mix of common benefit fees, contingency fees and payments to the states for outside counsel. One law professor said, "it's not like the lawyers are going to be impoverished."
9 minute read

Resources

  • Blueprint for Successful Second Request Document Review

    Brought to you by Integreon

    Download Now

  • Employee Happiness Playbook: The 3 R's for Business Success in 2024

    Brought to you by Amazing Workplace, Inc.

    Download Now

  • The Positive Impact of AI at Small Law Firms: 4 Key Insights

    Brought to you by LexisNexis®

    Download Now

  • Will Generative AIs Transform Legal Services? Defensibility and Security Must Be a Focus

    Brought to you by HaystackID

    Download Now

NEXT